Compare APGE & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APGE | LION |
|---|---|---|
| Founded | 2022 | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.1B |
| IPO Year | 2023 | 2025 |
| Metric | APGE | LION |
|---|---|---|
| Price | $134.75 | $11.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $109.67 | $11.89 |
| AVG Volume (30 Days) | 1.2M | ★ 2.3M |
| Earning Date | 05-12-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $2,631,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $22.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $35.39 | $5.88 |
| 52 Week High | $134.88 | $16.70 |
| Indicator | APGE | LION |
|---|---|---|
| Relative Strength Index (RSI) | 77.42 | 27.56 |
| Support Level | $134.03 | $9.11 |
| Resistance Level | $134.88 | $12.58 |
| Average True Range (ATR) | 0.20 | 0.55 |
| MACD | -0.75 | -0.08 |
| Stochastic Oscillator | 87.65 | 1.11 |
Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.